Company Filing History:
7 out of 9 
7 out of 106 
2 out of 2 
Years Active: 2008-2025
Title: **Juan Manuel Betancort: Innovator in Therapeutic Compounds and Bioassays**
Introduction
Juan Manuel Betancort is a prominent inventor based in San Diego, California. With 18 patents to his name, his work has significantly contributed to the fields of therapeutic compounds and optical imaging technologies. His innovative approach addresses critical medical challenges, particularly in the realm of epigenetic regulation and disease treatment.
Latest Patents
Among his latest patents, Betancort has pioneered the development of therapeutic compounds aimed at epigenetic regulation. His patent details substituted heterocyclic derivative compounds designed to inhibit bromodomain-mediated recognition of acetyl lysine regions of proteins, which are pivotal in cell signaling. These compounds show promise in treating diseases characterized by abnormal cell signaling, such as inflammatory disorders and cancer. Additionally, Betancort has developed phthalocyanine dye compounds and conjugates that serve as fluorescent reporters for bioassays and therapeutic conjugates in light-based therapies, including photoimmunotherapy. These dyes boast water solubility and favorable photophysical properties for effective imaging and therapeutic applications.
Career Highlights
Throughout his career, Juan Manuel Betancort has worked with reputable companies like Phenomix Corporation and Celgene Quanticel Research, Inc. His experiences in these organizations have honed his skills in research and development, allowing him to translate his innovative ideas into tangible medical applications.
Collaborations
Betancort has collaborated with distinguished professionals, including David Alan Campbell and David T. Winn. These collaborations have enriched his research endeavors and contributed to the advancement of his inventions.
Conclusion
Juan Manuel Betancort stands out as a noteworthy inventor whose contributions to therapeutic compounds and imaging technologies continue to make significant impacts in medical research and treatment. With 18 patents documenting his innovative spirit, Betancort exemplifies the role of inventors in addressing complex health challenges through cutting-edge solutions.